Dr. Syed M. Kazmi
Claim this profileUT Southwestern/Simmons Cancer Center-Dallas
Studies Colon Cancer
Studies Colorectal Cancer
17 reported clinical trials
33 drugs studied
Area of expertise
1Colon Cancer
Stage IV
Stage III
BRAF negative
2Colorectal Cancer
Stage IV
Stage III
MLH1 positive
Affiliated Hospitals
Clinical Trials Syed M. Kazmi is currently running
Circulating Tumor DNA
for Colorectal Cancer
This study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come back or spread. Tumors shed DNA and other cancer related chemicals into the blood that can be identified and studied further to provide information about the cancer. Information gathered from this study may help researchers better understand if ctDNA found in the blood can predict whether colorectal cancer may come back or spread.
Recruiting1 award N/A6 criteria
Ceralasertib + Trastuzumab Deruxtecan
for Solid Tumors
The dose escalation phase of this trial identifies the safety, side effects and best dose of ceralasertib (AZD6738) when given in combination with trastuzumab deruxtecan (DS-8201a) in treating patients with solid tumors that have a change (mutation) in the HER2 gene or protein and have spread to other places in the body (advanced). The dose expansion phase (phase Ib) of this trial compares how colorectal and gastroesophageal cancers with HER2 mutation respond to treatment with a combination of ceralasertib and trastuzumab deruxtecan versus trastuzumab deruxtecan alone. Ceralasertib may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Trastuzumab deruxtecan is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called deruxtecan. Trastuzumab attaches to HER2 positive cancer cells in a targeted way and delivers deruxtecan to kill them. Ceralasertib and trastuzumab deruxtecan may be safe, tolerable and effective in treating patients with advanced solid tumors expressing the HER2 protein or gene.
Recruiting1 award Phase 126 criteria
More about Syed M. Kazmi
Clinical Trial Related8 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Syed M. Kazmi has experience with
- Atezolizumab
- Nivolumab
- Cetuximab
- Bevacizumab
- Oxaliplatin
- Fluorouracil
Breakdown of trials Syed M. Kazmi has run
Colon Cancer
Colorectal Cancer
Pancreatic Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Syed M. Kazmi specialize in?
Syed M. Kazmi focuses on Colon Cancer and Colorectal Cancer. In particular, much of their work with Colon Cancer has involved Stage IV patients, or patients who are Stage III.
Is Syed M. Kazmi currently recruiting for clinical trials?
Yes, Syed M. Kazmi is currently recruiting for 3 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Syed M. Kazmi has studied deeply?
Yes, Syed M. Kazmi has studied treatments such as Atezolizumab, Nivolumab, Cetuximab.
What is the best way to schedule an appointment with Syed M. Kazmi?
Apply for one of the trials that Syed M. Kazmi is conducting.
What is the office address of Syed M. Kazmi?
The office of Syed M. Kazmi is located at: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas 75390 United States. This is the address for their practice at the UT Southwestern/Simmons Cancer Center-Dallas.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.